Genetic variants and response to cancer treatments

    loading  Checking for direct PDF access through Ovid

Abstract

The authors discuss new findings that single nucleotide polymorphisms in genes associated with off-target effects of antiangiogenesis agents have a bearing on clinical outcomes. This, in turn, reveals potential new targets for drug development.

Related Topics

    loading  Loading Related Articles